This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic and genomic changes has influenced the current outlook toward haematological malignancies. This recent and ongoing expansion of knowledge on malignant hematology has not previously been utilized to its full capacity due to its diffuse distribution scattered over the internet and research publications. This book is written by experts from the American and European continent, sharing their current thoughts and knowledge on the pathobiology of malignant haematological diseases of the blood, as well as current treatment strategies and future developments in the area of these haematological diseases.
Part 1: Hematopoiesis. 1 Normal and Malignant Hematopoiesis (Bijal D. Shah and Kenneth S. Zuckerman). 2 The Leukemic Genome (Jonathan C. Strefford and Nicholas CP Cross). Part 2: Myeloid Malignancies. 3 Myeloproliferative Neoplasms (Ruben A. Mesa and Ayalew Tefferi). 4 CML: Molecular Biology of BCR-Able (Javier I. Pinilla-Ibarz, Eric Padron and Lori Hazlehurst). 5 Standard Management of Patients with CML (Chronic Myeloid Leukemia) (Elias Jabbour, Jorge Cortes and Hagop Kantarjian). 6 The Molecular Biology of Acute Myeloid Leukemia (Jerald Radich). 7 Acute Myeloid Leukemia (Martin S. Tallman, Ritesh Parajuli and Jessica K. Altman). 8 Acute promyelocytic leukemia (APL) (Sylvain Thépot, Lionel Ades and Pierre Fenaux). 9 A Pluralistic approach to the study of myelodysplastic syndromes: Evolving pathology of the Seed via the Soil (Naomi Galili, Raymond Cruz, Jamie Stratton, Jessica Clima, Ghulam Sajjad Khan and Azra Raza). 10 Myelodysplastic Syndrome: A Review of Current Care (Kenneth H. Shain, Alan F. List and Rami S. Komrokji). 11 Supportive Care in Myelodysplastic Syndrome (MDS) (Hussain I. Saba, Arshia A. Dangol and Donald C. Doll). Part 3: Lymphoid Malignancies. 12 Molecular Biology of Chronic Lymphoproliferative Disorders (Monique A. Hartley and Lubomir Sokol). 13 Chronic Lymphocytic Leukemia (Terry Hamblin and Angela Hamblin). 14 Acute Lymphoblastic Leukemia (Susan O'Brien, Stefan Faderl, Deborah Thomas and Hagop M. Kantarjian). 15 Large Granular Lymphocyte Leukemia (Xin Liu and Thomas P. Loughran, Jr.). 16 Hairy Cell Leukemia (Kevin T. Kim, Darren S. Sigal and Alan Saven). 17 Molecular Basis of B-cell Lymphomas (Elizabeth M. Sagatys, Eduardo M. Sotomayor and Jianguo Tao). 18 Non-Hodgkin’s Lymphomas (Peter McLaughlin and Nathan Fowler). 19 Hodgkin Lymphoma (Michael Crump). Part 4: Plasma Cell Disorders. 20 Multiple Myeloma: Molecular Biology, Diagnosis and Treatment (S. Vincent Rajkumar and Shaji Kumar). 21 Waldenström’s Macroglobulinemia (Robert A. Kyle and Suzanne Hayman). 22 Primary Systemic (AL) Amyloidosis (Efstathios Kastritis and Meletios Athanasios Dimopoulos). Part 5: Bone Marrow Transplantation and Quality of Life. 23 Advances in allogeneic hematopoietic cell transplantation: progress in transplantation technology and disease-specific outcomes (Joseph Pidala and Claudio Anasetti). 24 Quality of Life after the diagnosis of Hematological Malignancies (Mohamed Sorror).
"This book provides a concise overview of topics in malignant hematology. The charts and tables offer excellent, quick reviews of topics. In addition, the contributors appear to be well-respected authorities in the field." (Doody's, 2 September 2011)
Hussain I. Saba, Department of Medicine, University of South Florida College of Medicine; James A. Haley Veterans Hospital; H. Lee Moffitt Cancer Center and Research Institute; , Tampa, FL, USA Ghulam Mufti, Department of Haematological Medicine, Guy’s and St. Thomas’s School of Medicine, King’s College Hospital, London, UK
Advances in Malignant Hematology captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic and genomic changes has influenced the current outlook toward malignant hematology. This recent and ongoing explosion of knowledge has not previously been captured and utilized to its full capacity due to its diffuse distribution over the internet and research publications. This comprehensive book is written by experts from the American and European continent, sharing their current thoughts and knowledge on the pathobiology of malignant hematological diseases, their current treatment strategies and future developments. The book is divided into five sections: Hematopoiesis Myeloid Malignancies Lymphoid Malignancies Plasma Cell Disorders Bone Marrow Transplantation and Quality of Life There was a time when the practicing hematologist could only offer treatment for the symptoms of malignant disease states. Now, treatment attempts are being offered to attack and eradicate diseases at their molecular level. In some instances this has helped to achieve a near cure, and perhaps a complete cure in the near future, for some of the hematological malignancies. Advances in Malignant Hematology provides significant help in the battle against hematologic cancer and will be valuable to hematologists in training and in practice.